{"entity":{"type":"insider","cik":"0001406834","url":"/insider/0001406834","json_url":"/insider/0001406834.json","name":"Kendall Keith J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":4,"first":"2018-11-26","last":"2020-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Kendall Keith J","source":"filing","n_filings":4,"first_seen":"2018-11-26","last_seen":"2020-06-05"}],"transactions":[{"id":2661026,"accession":"0001214659-20-005427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-005427","line_url":"/filing/0001214659-20-005427#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.1062,"price_display":"5.11","price_state":"stated","total_value":255310.0,"total_display":"255,310.00","total_whole":"255,310","shares_owned_after":638964.0,"shares_owned_after_display":"638,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-05","scope":"insider"},{"id":8012045,"accession":"0001214659-19-005387","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001214659-19-005387","line_url":"/filing/0001214659-19-005387","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.6735,"price_display":"3.67","price_state":"stated","total_value":7347.0,"total_display":"7,347.00","total_whole":"7,347","shares_owned_after":653581.0,"shares_owned_after_display":"653,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-20","scope":"insider","n_lines":2},{"id":8012038,"accession":"0001214659-19-005387","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-19-005387","line_url":"/filing/0001214659-19-005387#line-4","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.045,"price_display":"4.04","price_state":"stated","total_value":4045.0,"total_display":"4,045.00","total_whole":"4,045","shares_owned_after":652581.0,"shares_owned_after_display":"652,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-20","scope":"insider"},{"id":8012035,"accession":"0001214659-19-005387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-19-005387","line_url":"/filing/0001214659-19-005387","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.919,"price_display":"3.92","price_state":"stated","total_value":19595.0,"total_display":"19,595.00","total_whole":"19,595","shares_owned_after":651581.0,"shares_owned_after_display":"651,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-20","scope":"insider","n_lines":3},{"id":6347218,"accession":"0001140361-18-043897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-043897","line_url":"/filing/0001140361-18-043897#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.87,"price_display":"9.87","price_state":"stated","total_value":9870.0,"total_display":"9,870.00","total_whole":"9,870","shares_owned_after":621139.0,"shares_owned_after_display":"621,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-28","scope":"insider"},{"id":6445186,"accession":"0001140361-18-043651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-043651","line_url":"/filing/0001140361-18-043651#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1950.0,"shares_display":"1,950","price_per_share":9.9,"price_display":"9.90","price_state":"stated","total_value":19305.0,"total_display":"19,305.00","total_whole":"19,305","shares_owned_after":620139.0,"shares_owned_after_display":"620,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-23","filed_date":"2018-11-26","scope":"insider"},{"id":6445183,"accession":"0001140361-18-043651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-043651","line_url":"/filing/0001140361-18-043651#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406834","owner_name":"Kendall Keith J","owner_display_name":"Kendall Keith J","owner_url":"/insider/0001406834","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":10.17,"price_display":"10.17","price_state":"stated","total_value":61020.0,"total_display":"61,020.00","total_whole":"61,020","shares_owned_after":618189.0,"shares_owned_after_display":"618,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2018-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Director, Officer (CEO and President)","n_filings":4,"first_seen":"2018-11-26","last_seen":"2020-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001406834","retrieved_at":"2026-08-24T03:54:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}